相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevention of Antidrug Antibody Formation to Infliximab in Crohn's Patients With Prior Failure of Thiopurines
Haggai Bar-Yoseph et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial
Filip Baert et al.
GUT (2016)
Impact of New Treatments on Hospitalisation, Surgery, Infection, and Mortality in IBD: a Focus Paper by the Epidemiology Committee of ECCO
Vito Annese et al.
JOURNAL OF CROHNS & COLITIS (2016)
Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Optimizing biologic treatment in IBD: objective measures, but when, how and how often?
Shomron Ben-Horin et al.
BMC GASTROENTEROLOGY (2015)
Pharmacokinetics of Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Adding Value to Current Practice
Niels Vande Casteele et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Addition of an Immunomodulator as a Rescue Therapy for Loss of Response to Adalimumab Dose Escalation in Patients With Crohn's Disease
Konstantinos Papamichael et al.
JOURNAL OF CROHNS & COLITIS (2015)
Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease
C. Ma et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease
Y. Mazor et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Development of an Algorithm Incorporating Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases
Xavier Roblin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
A Systematic Review of Measurement of Endoscopic Disease Activity and Mucosal Healing in Crohn's Disease: Recommendations for Clinical Trial Design
Reena Khanna et al.
INFLAMMATORY BOWEL DISEASES (2014)
A Systematic Review of the Measurement of Endoscopic Healing in Ulcerative Colitis Clinical Trials: Recommendations and Implications for Future Research
Mark A. Samaan et al.
INFLAMMATORY BOWEL DISEASES (2014)
Extra-intestinal malignancies in inflammatory bowel disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (III)
Fernando Magro et al.
JOURNAL OF CROHNS & COLITIS (2014)
Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease
Shomron Ben-Horin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients
Filip Baert et al.
JOURNAL OF CROHNS & COLITIS (2013)
Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease
Benjamin Pariente et al.
INFLAMMATORY BOWEL DISEASES (2012)
Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review
Vincent Billioud et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Assessing Response and Loss of Response to Biological Therapies in IBD
Henit Yanai et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
The immunogenic part of infliximab is the F(ab ')(2), but measuring antibodies to the intact infliximab molecule is more clinically useful
Shomron Ben-Horin et al.
GUT (2011)
Risk of Cancer in Inflammatory Bowel Disease Treated With Azathioprine: A UK Population-Based Case-Control Study
Richard G. Armstrong et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Correlation Between the Crohn's Disease Activity and Harvey-Bradshaw Indices in Assessing Crohn's Disease Severity
Severine Vermeire et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects
Matthieu Allez et al.
JOURNAL OF CROHNS & COLITIS (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Early preservation of effector functions followed by eventual T cell memory depletion: a model for the delayed onset of the effect of thiopurines
S. Ben-Horin et al.
GUT (2009)
Adalimumab induction therapy for Crohn disease previously treated with infliximab - A randomized trial
William J. Sandborn et al.
ANNALS OF INTERNAL MEDICINE (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis
PDR Higgins et al.
GUT (2005)
分享论文
